Brought to you by 
Sorin Group makes another equity investment in Enopace Biomedical, gets option to buy
04 Aug 2022
Executive Summary
Sorin Group SPA has made another minority equity investment in Enopace Biomedical Ltd. and received an option to buy the company, which is focused on neuromodulation system for heart failure patients.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Includes M&A Option
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Sorin Group makes another equity investment in Enopace Biomedical, gets option to buy
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice